Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Collection Sub-Study of Exact Sciences Protocol 2018-10: "An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now"

NCT03741166 is registered in ClinicalTrials.gov with Exact Sciences Corporation as lead sponsor.

NCT NCT03741166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03741166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Collection Sub-Study of Exact Sciences Protocol 2018-10: "An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now"
Lead sponsor
Exact Sciences Corporation
Phase
Observational
Overall status
Completed
Start date
November 8, 2018
Completion date
April 5, 2019
Enrollment
871 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer